3666 related articles for article (PubMed ID: 27414503)
41. Genomic analysis of 1710 surveillance-based
Reimche JL; Clemons AA; Chivukula VL; Joseph SJ; Schmerer MW; Pham CD; Schlanger K; St Cyr SB; Kersh EN; Gernert KM; Antimicrobial-Resistant Working Group
Microb Genom; 2023 May; 9(5):. PubMed ID: 37171855
[TBL] [Abstract][Full Text] [Related]
42. Quality assurance for antimicrobial susceptibility testing of
Sawatzky P; Martin I; Galarza P; Carvallo MET; Araya Rodriguez P; Cruz OMS; Hernandez AL; Martinez MF; Borthagaray G; Payares D; Moreno JE; Chiappe M; Corredor AH; Thakur SD; Dillon JR
Sex Transm Infect; 2018 Nov; 94(7):479-482. PubMed ID: 29674407
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.
Cole MJ; Spiteri G; Town K; Unemo M; Hoffmann S; Chisholm SA; Amato-Gauci AJ; van de Laar M; Ison CA;
Sex Transm Dis; 2014 Dec; 41(12):723-9. PubMed ID: 25581808
[TBL] [Abstract][Full Text] [Related]
44. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
[TBL] [Abstract][Full Text] [Related]
45. Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.
Kirkcaldy RD; Soge O; Papp JR; Hook EW; del Rio C; Kubin G; Weinstock HS
Antimicrob Agents Chemother; 2015 Feb; 59(2):998-1003. PubMed ID: 25451056
[TBL] [Abstract][Full Text] [Related]
46. Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone.
Bharara T; Bhalla P; Rawat D; Garg VK; Sardana K; Chakravarti A
Indian J Med Microbiol; 2015; 33(1):39-42. PubMed ID: 25560000
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Java, Indonesia.
Ieven M; Van Looveren M; Sudigdoadi S; Rosana Y; Goossens W; Lammens C; Meheus A; Goossens H
Sex Transm Dis; 2003 Jan; 30(1):25-9. PubMed ID: 12514438
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
[TBL] [Abstract][Full Text] [Related]
49. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
[TBL] [Abstract][Full Text] [Related]
50. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
[TBL] [Abstract][Full Text] [Related]
51. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
[TBL] [Abstract][Full Text] [Related]
52. Antimicrobial susceptibility of Neisseria gonorrhoeae in Cuba (1995-1999): implications for treatment of gonorrhea.
Llanes R; Sosa J; Guzmán D; Llop A; Valdés EA; Martínez I; Palma S; Lantero MI
Sex Transm Dis; 2003 Jan; 30(1):10-4. PubMed ID: 12514435
[TBL] [Abstract][Full Text] [Related]
53. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
[TBL] [Abstract][Full Text] [Related]
54. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
[TBL] [Abstract][Full Text] [Related]
55. Trends and determinants of antimicrobial susceptibility of
Hofstraat SH; Götz HM; van Dam AP; van der Sande MA; van Benthem BH
Euro Surveill; 2018 Sep; 23(36):. PubMed ID: 30205870
[TBL] [Abstract][Full Text] [Related]
56. Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998.
Ye S; Su X; Wang Q; Yin Y; Dai X; Sun H
Sex Transm Dis; 2002 Apr; 29(4):242-5. PubMed ID: 11912467
[TBL] [Abstract][Full Text] [Related]
57. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
58. Correlates of
Blouin K; Lefebvre B; Trudelle A; Defay F; Perrault Sullivan G; Ezin Aloffan LND; Labbé AC
BMJ Open; 2023 Aug; 13(8):e073849. PubMed ID: 37541749
[TBL] [Abstract][Full Text] [Related]
59. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
[TBL] [Abstract][Full Text] [Related]
60. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.
Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y
Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
